ZNF805
gene geneOn this page
Summary
ZNF805 (zinc finger protein 805, HGNC:23272) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 805 (Q5CZA5). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 390980 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 89 total
- MANE Select transcript:
NM_001023563
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23272 |
| Approved symbol | ZNF805 |
| Name | zinc finger protein 805 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000204524 |
| Ensembl biotype | protein_coding |
| Entrez | 390980 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000354309, ENST00000414468
RefSeq mRNA: 2 — MANE Select: NM_001023563
NM_001023563, NM_001145078
CCDS: CCDS46207, CCDS46208
Canonical transcript exons
ENST00000414468 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002487809 | 57243923 | 57244049 |
| ENSE00002998094 | 57253073 | 57262728 |
| ENSE00003184276 | 57240632 | 57240921 |
| ENSE00003575963 | 57248605 | 57248700 |
Expression profiles
Bgee: expression breadth ubiquitous, 135 present calls, max score 81.51.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.6124 / max 123.7550, expressed in 1755 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177747 | 3.9435 | 1573 |
| 177746 | 2.3961 | 1362 |
| 177749 | 1.1269 | 733 |
| 177748 | 0.1460 | 51 |
Top tissues by expression
138 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 81.51 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.64 | gold quality |
| adrenal tissue | UBERON:0018303 | 78.18 | gold quality |
| corpus callosum | UBERON:0002336 | 76.39 | gold quality |
| bone marrow | UBERON:0002371 | 76.27 | gold quality |
| bone marrow cell | CL:0002092 | 76.04 | gold quality |
| colonic epithelium | UBERON:0000397 | 75.37 | gold quality |
| islet of Langerhans | UBERON:0000006 | 74.10 | gold quality |
| tonsil | UBERON:0002372 | 73.94 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.83 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 72.44 | gold quality |
| sural nerve | UBERON:0015488 | 71.39 | gold quality |
| ventricular zone | UBERON:0003053 | 70.89 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 70.88 | gold quality |
| muscle tissue | UBERON:0002385 | 70.83 | gold quality |
| leukocyte | CL:0000738 | 70.52 | gold quality |
| monocyte | CL:0000576 | 70.36 | gold quality |
| endometrium | UBERON:0001295 | 70.13 | gold quality |
| quadriceps femoris | UBERON:0001377 | 69.42 | gold quality |
| adrenal gland | UBERON:0002369 | 68.87 | gold quality |
| cortical plate | UBERON:0005343 | 68.79 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 68.56 | gold quality |
| urinary bladder | UBERON:0001255 | 68.56 | gold quality |
| ganglionic eminence | UBERON:0004023 | 68.37 | gold quality |
| granulocyte | CL:0000094 | 68.04 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 67.87 | gold quality |
| muscle of leg | UBERON:0001383 | 67.79 | gold quality |
| cerebellar vermis | UBERON:0004720 | 67.75 | gold quality |
| gastrocnemius | UBERON:0001388 | 67.64 | gold quality |
| lung | UBERON:0002048 | 67.58 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.27 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
298 targeting ZNF805, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300)
Protein
Protein identifiers
Zinc finger protein 805 — Q5CZA5 (reviewed: Q5CZA5)
All UniProt accessions (1): Q5CZA5
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Miscellaneous. Gene prediction based on similarity to orthologs.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5CZA5-1 | 1 | yes |
| Q5CZA5-2 | 2 |
RefSeq proteins (2): NP_001018857, NP_001138550 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF13465
UniProt features (21 total): zinc finger region 13, region of interest 2, compositionally biased region 2, chain 1, domain 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5CZA5-F1 | 68.54 | 0.18 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 81 (showing top):
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN, DODD_NASOPHARYNGEAL_CARCINOMA_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, ZWANG_DOWN_BY_2ND_EGF_PULSE, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CBX7_TARGET_GENES, CEBPZ_TARGET_GENES, CHAF1B_TARGET_GENES, DIDO1_TARGET_GENES, TRIP13_TARGET_GENES, ZNF7_TARGET_GENES, ZNF711_TARGET_GENES, MIR616_5P, MIR371B_5P, MIR373_5P
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872), sequence-specific double-stranded DNA binding (GO:1990837)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
268 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF805 | KATNBL1 | Q9H079 | 509 |
| ZNF805 | C2CD2 | Q9Y426 | 505 |
| ZNF805 | INTS2 | Q9H0H0 | 478 |
| ZNF805 | N4BP2L2 | Q92802 | 464 |
| ZNF805 | THEM5 | Q8N1Q8 | 461 |
| ZNF805 | SLC25A51 | Q9H1U9 | 454 |
| ZNF805 | TRAPPC1 | Q9Y5R8 | 436 |
| ZNF805 | GTF2IRD2B | Q6EKJ0 | 434 |
| ZNF805 | GTF2IRD2 | Q86UP8 | 432 |
| ZNF805 | PCNX1 | Q96RV3 | 417 |
| ZNF805 | PARP11 | Q9NR21 | 403 |
| ZNF805 | RNF149 | Q8NC42 | 400 |
| ZNF805 | C2CD4B | A6NLJ0 | 400 |
| ZNF805 | PCDHA5 | Q9Y5H7 | 391 |
| ZNF805 | ARHGAP6 | O43182 | 387 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| CLEC11A | VWA8 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF264 | TRIM24 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (9): ZNF805 (Affinity Capture-MS), ZNF805 (Proximity Label-MS), ZNF805 (Affinity Capture-RNA), ZNF805 (Affinity Capture-MS), ZNF805 (Affinity Capture-MS), ZNF805 (Affinity Capture-MS), ZNF805 (Affinity Capture-MS), ZNF805 (Affinity Capture-MS), ZNF805 (Affinity Capture-MS)
ESM2 similar proteins: A0A087WUV0, A0JNB1, A2VDP4, B2RUI1, P0CG31, P10072, P17025, P17036, P17097, P18733, P51814, Q08ER8, Q09FC8, Q0VGE8, Q14590, Q15937, Q16600, Q2M3X9, Q4V8A8, Q5CZA5, Q5R8G9, Q5RBX0, Q5VIY5, Q68DI1, Q6J6I6, Q6NX49, Q6P1L6, Q6PG37, Q6ZMS4, Q6ZMW2, Q80YP6, Q86UD4, Q86Y25, Q8IZ26, Q8N184, Q8NB42, Q8NEK5, Q8TAF7, Q8TF47, Q8WXB4
Diamond homologs: A0JPL0, A2A761, A3KN32, A3KN36, A6NFI3, A6NM28, A6QLU5, A6QPT6, A7MBI1, A8MTY0, B2RXC5, B4DU55, E9PYI1, O14978, O60765, O75467, O75820, O95780, P0C7X2, P0DKX0, P0DPD5, P10072, P15622, P16374, P17014, P17023, P17032, P17098, P51523, P51786, P52738, P52742, Q02975, Q06732, Q08DG8, Q08ER8, Q0VCB0, Q14590, Q14929, Q29RZ4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
89 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 74 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
436 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:57243918:TTCA:T | acceptor_loss | 1.0000 |
| 19:57243919:TCAG:T | acceptor_loss | 1.0000 |
| 19:57243920:CAGGT:C | acceptor_loss | 1.0000 |
| 19:57243921:A:AC | acceptor_loss | 1.0000 |
| 19:57243922:GGT:G | acceptor_gain | 1.0000 |
| 19:57244048:GG:G | donor_gain | 1.0000 |
| 19:57244049:GG:G | donor_gain | 1.0000 |
| 19:57244049:GGT:G | donor_loss | 1.0000 |
| 19:57244050:G:GA | donor_loss | 1.0000 |
| 19:57244051:TAA:T | donor_loss | 1.0000 |
| 19:57240920:AGGTG:A | donor_loss | 0.9900 |
| 19:57240922:GT:G | donor_loss | 0.9900 |
| 19:57240923:T:G | donor_loss | 0.9900 |
| 19:57243922:GGTGT:G | acceptor_gain | 0.9900 |
| 19:57244010:G:GT | donor_gain | 0.9900 |
| 19:57244050:G:GG | donor_gain | 0.9900 |
| 19:57253067:TTTCA:T | acceptor_loss | 0.9900 |
| 19:57253068:TTCA:T | acceptor_loss | 0.9900 |
| 19:57253069:TCAG:T | acceptor_loss | 0.9900 |
| 19:57253070:CA:C | acceptor_loss | 0.9900 |
| 19:57253071:A:AG | acceptor_gain | 0.9900 |
| 19:57253072:G:A | acceptor_loss | 0.9900 |
| 19:57253072:G:GG | acceptor_gain | 0.9900 |
| 19:57253072:GGT:G | acceptor_gain | 0.9900 |
| 19:57240918:GCAG:G | donor_gain | 0.9800 |
| 19:57240922:G:GG | donor_gain | 0.9800 |
| 19:57243921:A:AG | acceptor_gain | 0.9800 |
| 19:57243922:G:GG | acceptor_gain | 0.9800 |
| 19:57248604:GGGT:G | acceptor_gain | 0.9800 |
| 19:57243916:A:AG | acceptor_gain | 0.9700 |
AlphaMissense
4169 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:57254228:T:C | L470P | 1.000 |
| 19:57253705:T:C | F296L | 0.999 |
| 19:57253707:C:A | F296L | 0.999 |
| 19:57253707:C:G | F296L | 0.999 |
| 19:57253957:T:C | F380L | 0.999 |
| 19:57253959:C:A | F380L | 0.999 |
| 19:57253959:C:G | F380L | 0.999 |
| 19:57254041:T:C | F408L | 0.999 |
| 19:57254043:C:A | F408L | 0.999 |
| 19:57254043:C:G | F408L | 0.999 |
| 19:57254068:C:G | H417D | 0.999 |
| 19:57254075:G:C | R419P | 0.999 |
| 19:57254125:T:C | F436L | 0.999 |
| 19:57254127:C:A | F436L | 0.999 |
| 19:57254127:C:G | F436L | 0.999 |
| 19:57254209:T:C | F464L | 0.999 |
| 19:57254211:T:A | F464L | 0.999 |
| 19:57254211:T:G | F464L | 0.999 |
| 19:57254234:G:C | R472P | 0.999 |
| 19:57254238:C:A | H473Q | 0.999 |
| 19:57254238:C:G | H473Q | 0.999 |
| 19:57254293:T:C | F492L | 0.999 |
| 19:57254295:C:A | F492L | 0.999 |
| 19:57254295:C:G | F492L | 0.999 |
| 19:57254327:G:C | R503P | 0.999 |
| 19:57254377:T:C | F520L | 0.999 |
| 19:57254379:T:A | F520L | 0.999 |
| 19:57254379:T:G | F520L | 0.999 |
| 19:57254396:T:C | L526P | 0.999 |
| 19:57254461:T:C | F548L | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000022801 (19:57246371 A>G), RS1000196582 (19:57249430 AT>A), RS1000223249 (19:57249731 A>T), RS1000379830 (19:57241283 C>G), RS1000386203 (19:57239529 C>CAT), RS1000399749 (19:57245515 C>G,T), RS1000467147 (19:57239690 A>G), RS1000654443 (19:57262940 A>G), RS1000668149 (19:57252430 A>C), RS1000684007 (19:57256373 G>GT), RS1000902854 (19:57259921 A>G), RS1000946660 (19:57246519 T>C), RS1001308238 (19:57239471 AAAATATATATAT>A,AAAATATATATATAAATATATATAT), RS1001383609 (19:57249606 A>T), RS1001519061 (19:57255807 A>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
32 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, affects expression | 4 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 2 |
| Air Pollutants | increases abundance, increases expression, decreases expression | 2 |
| Cyclosporine | increases expression, increases methylation | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | increases expression | 1 |
| beta-lapachone | increases expression | 1 |
| manganese chloride | increases abundance, increases expression, affects cotreatment | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| jinfukang | decreases expression | 1 |
| NSC 689534 | affects binding, increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Vorinostat | decreases expression | 1 |
| Leflunomide | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Coal | decreases expression, increases abundance | 1 |
| Copper | increases expression, affects binding | 1 |
| Doxorubicin | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Manganese | increases abundance, increases expression, affects cotreatment | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Smoke | decreases expression, increases abundance | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.